Skip to content
Homepage
Author:
Waldencast plc
Posted Date:
June 1, 2026
Waldencast Announces Sale of Obagi Medical to Bridgepoint
Waldencast plc
June 1, 2026
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
Waldencast plc
May 15, 2026
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
Waldencast plc
May 14, 2026
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
Waldencast plc
April 30, 2026
Waldencast announces conclusion of SEC investigation
Waldencast plc
April 28, 2026
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
Waldencast plc
March 24, 2026
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
Waldencast plc
March 19, 2026
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
Waldencast plc
March 11, 2026
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Waldencast plc
February 27, 2026
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Waldencast plc
February 7, 2026
1
2
Next
